ANI Pharmaceuticals (BSFA) Revenue

0 Followers

ANI Pharmaceuticals Revenue

ANI Pharmaceuticals had a revenue of 266.04M in the quarter ending Jun 30, 2026, with 12.04%. This bring the company's revenue in the last twelve months to 978.38M, Decreased 5.92%. In the fiscal year ending Dec 31, 2025, ANI Pharmaceuticals had annual revenue of 883.37M with 43.78% growth.

Revenue (ttm)

978.38M

Revenue Growth

30.90%

P/S Ratio

1.52

Revenue/Employee

CHF910,687

Employees

970

Market Cap

CHF1.34B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	883.37M	268.99M	+43.78%
Dec 31, 2024	614.38M	127.56M	+26.20%
Dec 31, 2023	486.82M	170.43M	+53.87%
Dec 31, 2022	316.38M	100.25M	+46.38%
Dec 31, 2021	216.14M	7.66M	+3.67%
Dec 31, 2020	208.47M	1.93M	+0.93%
Dec 31, 2019	206.55M	4.97M	+2.47%
Dec 31, 2018	201.58M	24.73M	+13.99%
Dec 31, 2017	176.84M	―	―